These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Acquired von Willebrand syndrome: an update. Franchini M; Lippi G Am J Hematol; 2007 May; 82(5):368-75. PubMed ID: 17133419 [TBL] [Abstract][Full Text] [Related]
3. Use of intravenous immunoglobulin in patients with acquired von Willebrand syndrome. Federici AB Hum Immunol; 2005 Apr; 66(4):422-30. PubMed ID: 15866707 [TBL] [Abstract][Full Text] [Related]
4. Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome: a 2013 update. Federici AB; Budde U; Castaman G; Rand JH; Tiede A Semin Thromb Hemost; 2013 Mar; 39(2):191-201. PubMed ID: 23397553 [TBL] [Abstract][Full Text] [Related]
5. Clinical, laboratory and therapeutic aspects of platelet-type von Willebrand disease. Franchini M; Montagnana M; Lippi G Int J Lab Hematol; 2008 Apr; 30(2):91-4. PubMed ID: 18333841 [TBL] [Abstract][Full Text] [Related]
6. Diagnosis and management of acquired von Willebrand syndrome. Federici AB; Mannucci PM Clin Adv Hematol Oncol; 2003 Mar; 1(3):169-75. PubMed ID: 16224398 [TBL] [Abstract][Full Text] [Related]
7. Acquired von Willebrand syndrome: diagnostic problems and therapeutic options. Eikenboom JC; Tjernberg P; Van Marion V; Heering KJ Am J Hematol; 2007 Jan; 82(1):55-8. PubMed ID: 16986130 [TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of acquired von Willebrand syndrome. Tiede A Thromb Res; 2012 Dec; 130 Suppl 2():S2-6. PubMed ID: 23439003 [TBL] [Abstract][Full Text] [Related]
9. Acquired von Willebrand syndrome: data from an international registry. Federici AB; Rand JH; Bucciarelli P; Budde U; van Genderen PJ; Mohri H; Meyer D; Rodeghiero F; Sadler JE; Thromb Haemost; 2000 Aug; 84(2):345-9. PubMed ID: 10959711 [TBL] [Abstract][Full Text] [Related]
10. Association of acquired von Willebrand syndrome with AL amyloidosis. Kos CA; Ward JE; Malek K; Sanchorawala V; Wright DG; O'Hara C; Connors L; Skinner M; Seldin DC Am J Hematol; 2007 May; 82(5):363-7. PubMed ID: 17205535 [TBL] [Abstract][Full Text] [Related]
11. Acquired von Willebrand's disease associated with gastrointestinal angiodysplasia: a case report. Gupta PK; Kannan M; Chatterjee T; Dixit A; Mahapatra M; Choudhry VP; Saxena R Haemophilia; 2006 Jul; 12(4):452-5. PubMed ID: 16834752 [TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of acquired von Willebrand disease: a concise review. Shetty S; Kasatkar P; Ghosh K Eur J Haematol; 2011 Aug; 87(2):99-106. PubMed ID: 21535159 [TBL] [Abstract][Full Text] [Related]
13. Acquired von Willebrand factor abnormalities in myeloproliferative disorders and other hematologic diseases: a retrospective analysis by a single institution. Sánchez-Luceros A; Meschengieser SS; Woods AI; Blanco AN; Kempfer AC; Casais P; Salviú MJ; Lazzari MA Haematologica; 2002 Mar; 87(3):264-70. PubMed ID: 11869938 [TBL] [Abstract][Full Text] [Related]
14. [Von Willebrand disease: a common and unrecognized bleeding disorder]. Boehlen F; Robert-Ebadi H; de Moerloose P Rev Med Suisse; 2007 Feb; 3(97):346-50. PubMed ID: 17370733 [TBL] [Abstract][Full Text] [Related]
15. Phenotypic identification of platelet-type von Willebrand disease and its discrimination from type 2B von Willebrand disease: a question of 2B or not 2B? A story of nonidentical twins? Or two sides of a multidenominational or multifaceted primary-hemostasis coin? Favaloro EJ Semin Thromb Hemost; 2008 Feb; 34(1):113-27. PubMed ID: 18393148 [TBL] [Abstract][Full Text] [Related]
16. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Nichols WL; Hultin MB; James AH; Manco-Johnson MJ; Montgomery RR; Ortel TL; Rick ME; Sadler JE; Weinstein M; Yawn BP Haemophilia; 2008 Mar; 14(2):171-232. PubMed ID: 18315614 [TBL] [Abstract][Full Text] [Related]
17. Acquired von Willebrand syndrome associated with hypothyroidism: a mild bleeding disorder to be further investigated. Federici AB Semin Thromb Hemost; 2011 Feb; 37(1):35-40. PubMed ID: 21305800 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic studies with FVIII/von Willebrand factor concentrate can be a diagnostic tool to distinguish between subgroups of patients with acquired von Willebrand syndrome. Luboshitz J; Lubetsky A; Schliamser L; Kotler A; Tamarin I; Inbal A Thromb Haemost; 2001 May; 85(5):806-9. PubMed ID: 11372672 [TBL] [Abstract][Full Text] [Related]
19. Acquired von Willebrand syndrome--report of 10 cases and review of the literature. Nitu-Whalley IC; Lee CA Haemophilia; 1999 Sep; 5(5):318-26. PubMed ID: 10583513 [TBL] [Abstract][Full Text] [Related]
20. Acquired von Willebrand syndrome: experience from 2 years in a single laboratory compared with data from the literature and an international registry. Budde U; Bergmann F; Michiels JJ Semin Thromb Hemost; 2002 Apr; 28(2):227-38. PubMed ID: 11992245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]